G Medical Innovations Holdings Ltd. Announces Receipt of Nasdaq Minimum Bid Price Notification

3 years ago

Rehovot, Israel, May 19, 2023 (GLOBE NEWSWIRE) --  G Medical Innovations Holdings Ltd. (Nasdaq: GMVD) (the “Company”), a telehealth, medical…

Tempest Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

3 years ago

BRISBANE, Calif., May 19, 2023 (GLOBE NEWSWIRE) -- Tempest Therapeutics, Inc. (Nasdaq: TPST), a clinical-stage oncology company developing first-in-class1 therapeutics…

Hepion Pharmaceuticals Schedules Conference Call to Review Topline Results from Phase 2 ‘ALTITUDE-NASH’ Liver Function Trial of Rencofilstat

3 years ago

EDISON, N.J., May 19, 2023 (GLOBE NEWSWIRE) -- Hepion Pharmaceuticals, Inc. (NASDAQ:HEPA), a clinical stage biopharmaceutical company focused on Artificial…

Journey Medical Corporation to Announce First Quarter 2023 Financial Results on May 22, 2023

3 years ago

Company to host conference call to discuss financial results and provide a corporate update on May 22, 2023 at 4:30…

Calithera Biosciences Announces Update on Complete Liquidation and Dissolution

3 years ago

Special Meeting to be Held on or about June 29, 2023 with a Record Date of May 25, 2023SOUTH SAN…

Eascra Biotech Research Blasts Off with Ax-2 Launch

3 years ago

Eascra Biotech Exploring Space Manufacturing Options on the International Space StationBOSTON, May 19, 2023 (GLOBE NEWSWIRE) -- Research from Eascra…

Lucy Scientific Discovery Inc. Announces Sponsorship at the Psychedelic Science Conference June 19-25, 2023

3 years ago

VANCOUVER, British Columbia, May 19, 2023 (GLOBE NEWSWIRE) -- Lucy Scientific Discovery Inc. (“Lucy” or “the Company”) (NASDAQ: LSDI), a…

Mount Sinai Brooklyn Expands Cancer Services, Infusion Center in $4 Million Project

3 years ago

Also installs high-tech MRI scanner to serve broader set of patients Mount Sinai Brooklyn Infusion Center/Breast Center Opening Event Dr.…

Smart for Life Announces Closing of $1.58 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

3 years ago

MIAMI, May 19, 2023 (GLOBE NEWSWIRE) -- Smart for Life, Inc. (Nasdaq: SMFL) (“Smart for Life” or the “Company”), a…

Krystal Biotech Receives FDA Approval for the First-Ever Redosable Gene Therapy, VYJUVEK™ (beremagene geperpavec-svdt) for the Treatment of Dystrophic Epidermolysis Bullosa

3 years ago

Krystal Biotech Receives FDA Approval for the First-Ever Redosable Gene Therapy, VYJUVEK™ (beremagene geperpavec) for the Treatment of Dystrophic Epidermolysis…